Enamines
Selleck Chemical LLC Levamlodipine Besylate-25MG
Levamlodipine Besylate is a powerful dihydropyridine calcium channel blocker possessing vasodilation properties and used in the treatment of hypertension and angina
Selleck Chemical LLC Amlodipine S1905-1g
Amlodipine (UK-48340) is a long-acting calcium channel blocker used to lower blood pressure and prevent chest pain
Apexbio Technology LLC Amlodipine 88150-42-9 10mM (in 1mL DMSO)
Amlodipine (CAS 88150-42-9) is a dihydropyridine-based small molecule that functions as a long-acting calcium channel blocker It selectively inhibits L-type calcium channels on vascular smooth muscle and cardiac myocytes thereby reducing intracellular calcium influx This action leads to vasodilation and decreased vascular resistance Amlodipine is widely utilized in biomedical research to investigate calcium signaling pathways vascular tone modulation and cardiovascular pharmacology Its mechanistic profile also makes it a reference compound in studies evaluating novel antihypertensive or vasodilatory agents
Selleck Chemical LLC Nimodipine S1747-10mM/1mL
Nimodipine (BAY E 9736) is a dihydropyridine calcium channel blocker and an autophagy inhibitor used in the treatment of high blood pressure
Medchemexpress LLC PF-562271 besylate | 939791-38-5 | MFCD14105612 | 99.2% | 665.66 g·mol⁻¹ | C27H26F3N7O6S2 | 25 MG
PF-562271 besylate is a small-molecule, ATP-competitive and reversible inhibitor of focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2). It exhibits low-nanomolar potency in biochemical assays and is used in biochemical and cell-based studies to investigate FAK/Pyk2 signaling, cell migration, and cancer-related pathways. Supplied as a high-purity solid for research use.
- Potent ATP-competitive, reversible inhibition of FAK and Pyk2.
- Low-nanomolar biochemical potency (FAK IC50 ≈ 1.5 nM; Pyk2 IC50 ≈ 13 nM).
- Suitable for biochemical and cell-based assays investigating signaling and migration.
- High purity appropriate for research applications.
- Soluble in DMSO and largely insoluble in water.
- Available in small research pack sizes for laboratory studies.
Accela Chembio Inc Diethyl 1 | 4-dihydro-2 | 6-dimethyl-3 | 5-pyridinedicarboxylate | 100g | 1149-23-1 | MFCD00005951 | 97+% | Shelf Life: 900 Days | Light Sensitive
Diethyl 1 | 4-dihydro-2 | 6-dimethyl-3 | 5-pyridinedicarboxylate | 100g | 1149-23-1 | MFCD00005951 | 97+% | Shelf Life: 900 Days | Light Sensitive
Accela Chembio Inc Diethyl 1 | 4-dihydro-2 | 6-dimethyl-3 | 5-pyridinedicarboxylate | 25g | 1149-23-1 | MFCD00005951 | 97+% | Shelf Life: 900 Days | Light Sensitive
Diethyl 1 | 4-dihydro-2 | 6-dimethyl-3 | 5-pyridinedicarboxylate | 25g | 1149-23-1 | MFCD00005951 | 97+% | Shelf Life: 900 Days | Light Sensitive
![Medchemexpress LLC N-hydroxy-3-[1-(phenylsulfanylmethyl)triazol-4-yl]benzamide | 1316652-41-1 | MFCD21363002 | 99.3% | 326.37 g/mol | C16H14N4O2S | 100 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000227588.png-250.jpg)
Medchemexpress LLC N-hydroxy-3-[1-(phenylsulfanylmethyl)triazol-4-yl]benzamide | 1316652-41-1 | MFCD21363002 | 99.3% | 326.37 g/mol | C16H14N4O2S | 100 MG
NCC-149 (CAS 1316652-41-1) is a selective histone deacetylase 8 (HDAC8) inhibitor used in neural differentiation and other HDAC8-targeted research. The compound has molecular formula C16H14N4O2S and a molecular weight of 326.37 g/mol. Certificate of analysis lists purity ~99.3%. Store powder at -20°C for long-term stability. For research use only.
- Selective HDAC8 inhibitor suitable for target validation and neural differentiation assays.
- Validated molecular identity: C16H14N4O2S; MW 326.37 g/mol.
- High purity reported by COA (≈99.3%).
- Available in multiple pack sizes, including 100 MG.
- Powder storage at -20°C extends shelf life; follow SDS for solvent storage recommendations.
- Supporting documentation available: SDS and COA for handling and quality verification.
Sigma Aldrich Fine Chemicals Biosciences Nilvadipine >=98% (HPLC) | 75530-68-6 | 50MG
Nilvadipine >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 385.37 | 75530-68-6 | 50MG
Medchemexpress LLC VU6004256 | 1316652-41-1 | 98.7% | 326.37 | C16H14N4O2S | 50 MG
NCC-149 is a selective histone deacetylase 8 (HDAC8) inhibitor for laboratory research, described for use in neural differentiation studies. It is supplied as a solid powder and is also offered as a 10 mM solution in DMSO. Typical purity is approximately 98.7%, and the molecular weight is 326.37 g·mol⁻¹.
- Selective HDAC8 inhibitor for neural differentiation research.
- Available as solid powder and 10 mM solution in DMSO.
- Typical purity approximately 98.7%.
- Molecular weight 326.37 g·mol⁻¹ and formula C16H14N4O2S.
- Intended for laboratory research use only.
Medchemexpress LLC ALLO-2 | 1316652-41-1 | 98.7% | 326.37 g·mol⁻¹ | C16H14N4O2S | 25 MG
NCC-149 is a selective histone deacetylase 8 (HDAC8) inhibitor used in research on neural differentiation and HDAC8-related signaling pathways. It is supplied as a high-purity solid for laboratory use and is commonly prepared as a DMSO stock for cellular and biochemical assays.
- Selective HDAC8 inhibition for targeted epigenetic studies.
- Suitable for neural differentiation experiments and mechanistic research.
- High reported purity for reproducible experimental results.
- Available in small milligram pack sizes for screening and assay development.
- Soluble in DMSO for preparation of concentrated stock solutions.
Medchemexpress LLC (R)-Amlodipine | 103129-81-3 | 99.5% | 5 MG
(R)-Amlodipine is the R-enantiomer of Amlodipine. This compound is intended for research use only and is not suitable for patient use.
- High purity: 99.45%
- Documentation available: data sheet, COA, SDS, handling instructions, HNMR, LCMS
- Detailed solubility information provided for in vitro and in vivo dissolution
- Related research tools, antibodies, and screening libraries are available
- Classified under membrane transporter/ion channel, neuronal signaling, and calcium channel
- Related to disease areas such as blood or cardio-cerebrovascular disease, cancer, and cardiovascular disease
Sigma Aldrich Fine Chemicals Biosciences Amlodipine besylate United States Pharmacopeia (USP) Reference Standard | 111470-99-6 | MFCD00887594 | 350MG
Amlodipine besylate United States Pharmacopeia (USP) Reference Standard | Mol Wt: 567.05 | 111470-99-6 | MFCD00887594 | 350MG
Sigma Aldrich Fine Chemicals Biosciences Amlodipine besylate >=98% (HPLC) | 111470-99-6 | MFCD00887594 | 50MG
Amlodipine besylate >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 567.05 | 111470-99-6 | MFCD00887594 | 50MG